Literature DB >> 18947524

National seasonal influenza vaccination survey in Europe, 2008.

J Mereckiene1, S Cotter, A Nicoll, D Levy-Bruhl, A Ferro, G Tridente, G Zanoni, P Berra, S Salmaso, D O'Flanagan, D O Flanagan.   

Abstract

A cross-sectional survey was undertaken with the European Union (EU) Member States and Norway and Iceland to describe seasonal influenza immunisation in the 2006-7 season, in particular to identify country-specific recommendations for risk groups, obtain vaccine uptake information and allow comparison with global recommendations. A standardised questionnaire was completed electronically by each country's project gatekeeper. Of the 29 countries surveyed, 28 recommended seasonal influenza vaccination for older age groups (22 for those aged > 65 years), and in one country vaccine was recommended for all age groups. All countries recommended vaccinating patients with chronic pulmonary and cardiovascular diseases and most countries advised to immunise patients with haematologic or metabolic disorders (n=28), immunologic disorders (n=27) and renal disease (n=27), as well as residents of long-term care facilities (n=24). Most countries recommended vaccination for staff in hospitals (n=25), long-term care facilities (n=25) and outpatient clinics (n=23), and one-third had such recommendations for workers in essential (n=10), military (n=10) and veterinary services (n=10) and poultry industry (n=13). Eight countries recommended vaccine for pregnant women; and five advised to vaccinate children (with age limits ranging from 6 months to 5 years). Twenty countries measured influenza vaccine uptake among those aged > 65 years (range 1.8%-82.1%), seven reported uptake in healthcare workers (range 14%-48%) and seven assessed coverage in persons with underlying medical conditions (range 27.6%-75.2%). The data provided by this study can assist EU states to assess and compare their influenza vaccination programme performance with other countries. The information provides a comprehensive overview of policies and programmes and their outcomes and can be used to inform joint discussions on how the national policies in the EU might be standardised in the future to achieve optimal coverage. Annual surveys could be used to monitor changes in these national policies.

Entities:  

Mesh:

Year:  2008        PMID: 18947524     DOI: 10.2807/ese.13.43.19017-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  34 in total

Review 1.  Economic evaluations of childhood influenza vaccination: a critical review.

Authors:  Anthony T Newall; Mark Jit; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

Review 2.  Seasonal influenza vaccination campaigns for health care personnel: systematic review.

Authors:  Po-Po Lam; Larry W Chambers; Donna M Pierrynowski MacDougall; Anne E McCarthy
Journal:  CMAJ       Date:  2010-07-19       Impact factor: 8.262

3.  Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns.

Authors:  Laura Goodliffe; Brenda L Coleman; Allison J McGeer
Journal:  Hum Vaccin Immunother       Date:  2015-09-17       Impact factor: 3.452

4.  Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008-2010.

Authors:  Eduardo Azziz-Baumgartner; A S M Alamgir; Mustafizur Rahman; Nusrat Homaira; Badrul Munir Sohel; M A Yushuf Sharker; Rashid Uz Zaman; Jacob Dee; Emily S Gurley; Abdullah Al Mamun; Syeda Mah-E-Muneer; Alicia M Fry; Marc-Alain Widdowson; Joseph Bresee; Stephen Lindstrom; Tasnim Azim; Abdullah Brooks; Goutam Podder; M Jahangir Hossain; Mahmudur Rahman; Stephen P Luby
Journal:  Bull World Health Organ       Date:  2011-10-04       Impact factor: 9.408

Review 5.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  Influenza vaccination coverage among high-risk groups in 11 European countries.

Authors:  Adrian Loerbroks; Christian Stock; Jos A Bosch; David G Litaker; Christian J Apfelbacher
Journal:  Eur J Public Health       Date:  2011-07-12       Impact factor: 3.367

Review 7.  Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children.

Authors:  Vytautas Usonis; Ioana Anca; Francis André; Roman Chlibek; Inga Ivaskeviciene; Atanas Mangarov; Zsófia Mészner; Roman Prymula; Pavol Simurka; Eda Tamm; Goran Tesović
Journal:  BMC Infect Dis       Date:  2010-06-14       Impact factor: 3.090

8.  Influenza vaccine uptake among community-dwelling Italian elderly: results from a large cross-sectional study.

Authors:  Carlos Chiatti; Pamela Barbadoro; Giovanni Lamura; Lucia Pennacchietti; Francesco Di Stanislao; Marcello M D'Errico; Emilia Prospero
Journal:  BMC Public Health       Date:  2011-04-01       Impact factor: 3.295

9.  Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI) questionnaire.

Authors:  Catherine Chevat; Muriel Viala-Danten; Carla Dias-Barbosa; Van Hung Nguyen
Journal:  Health Qual Life Outcomes       Date:  2009-03-04       Impact factor: 3.186

10.  Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008.

Authors:  Rashid Uz Zaman; A S M Alamgir; Mustafizur Rahman; Eduardo Azziz-Baumgartner; Emily S Gurley; M Abu Yushuf Sharker; W Abdullah Brooks; Tasnim Azim; Alicia M Fry; Stephen Lindstrom; Larisa V Gubareva; Xiyan Xu; Rebecca J Garten; M Jahangir Hossain; Salah Uddin Khan; Labib Imran Faruque; Syeda Shegufta Ameer; Alexander I Klimov; Mahmudur Rahman; Stephen P Luby
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.